Browsing Over 990 Presentations

Sort By

PARPi maintenance: A new paradigm in the management of frontline ovarian cancer (ID 1784)

What’s new in metastatic pancreatic cancer management? (ID 1785)

Q&A (ID 1787)

Closing (ID 1788)

Biosimilars use in oncology: Clarifying concepts Special Session

Welcoming remarks

Lecture Time
04:30 PM - 04:35 PM
Session Name
Biosimilars use in oncology: Clarifying concepts
Speakers
  • Josep Tabernero
Location
Room 311, Singapore, Singapore, Singapore
Date
Fri, 22.11.2019
Time
04:30 PM - 06:00 PM
Authors
  • Josep Tabernero
Biosimilars use in oncology: Clarifying concepts Special Session

Biosimilars use in clinical practice (Example of the EU)

Lecture Time
04:35 PM - 04:55 PM
Session Name
Biosimilars use in oncology: Clarifying concepts
Speakers
  • Rosa Giuliani
Location
Room 311, Singapore, Singapore, Singapore
Date
Fri, 22.11.2019
Time
04:30 PM - 06:00 PM
Authors
  • Rosa Giuliani
Biosimilars use in oncology: Clarifying concepts Special Session

Clarifying immunogenicity, switching & extrapolation in oncology biosimilars

Lecture Time
04:55 PM - 05:15 PM
Session Name
Biosimilars use in oncology: Clarifying concepts
Speakers
  • Gouri Shankar Bhattacharyya
Location
Room 311, Singapore, Singapore, Singapore
Date
Fri, 22.11.2019
Time
04:30 PM - 06:00 PM
Authors
  • Gouri Shankar Bhattacharyya
Biosimilars use in oncology: Clarifying concepts Special Session

Do biosimilars really save cost in practice?

Lecture Time
05:15 PM - 05:35 PM
Session Name
Biosimilars use in oncology: Clarifying concepts
Speakers
  • Partha Basumatary
Location
Room 311, Singapore, Singapore, Singapore
Date
Fri, 22.11.2019
Time
04:30 PM - 06:00 PM
Authors
  • Partha Basumatary
Biosimilars use in oncology: Clarifying concepts Special Session

Panel discussion

Lecture Time
05:35 PM - 05:55 PM
Session Name
Biosimilars use in oncology: Clarifying concepts
Location
Room 311, Singapore, Singapore, Singapore
Date
Fri, 22.11.2019
Time
04:30 PM - 06:00 PM
Biosimilars use in oncology: Clarifying concepts Special Session

Concluding remarks

Lecture Time
05:55 PM - 06:00 PM
Session Name
Biosimilars use in oncology: Clarifying concepts
Speakers
  • Josep Tabernero
Location
Room 311, Singapore, Singapore, Singapore
Date
Fri, 22.11.2019
Time
04:30 PM - 06:00 PM
Authors
  • Josep Tabernero
Challenges in the management of clinical stage N2 disease Multidisciplinary tumour board

Presentation of case/condition

Lecture Time
09:15 AM - 09:20 AM
Session Name
Challenges in the management of clinical stage N2 disease
Speakers
  • Sanjay Popat
Location
Hall 404, Singapore, Singapore, Singapore
Date
Sun, 24.11.2019
Time
09:15 AM - 10:45 AM
Authors
  • Sanjay Popat
Challenges in the management of clinical stage N2 disease Multidisciplinary tumour board

Medical oncologist’s perspective

Lecture Time
09:20 AM - 09:40 AM
Session Name
Challenges in the management of clinical stage N2 disease
Speakers
  • Enriqueta Felip
Location
Hall 404, Singapore, Singapore, Singapore
Date
Sun, 24.11.2019
Time
09:15 AM - 10:45 AM
Authors
  • Enriqueta Felip